Posted: May 31st, 2017
District Court The Hague, The Netherlands, 12 May 2017, Case No. ECLI:NL:RBDHA:2017:5035 Injunction against biosimilar of Retuximab denied. Reasonable chance that the patent will be invalidated due to added matter. A copy of the judgment can be read here.
READ MOREPosted: May 24th, 2017
Curt G Joa, Inc v Fameccanica Data SpA, UK, Intellectual Property Enterprise Court, Hacon HHJ, 24 May 2017 This case concerned a patent for “disposable absorbent garments”, including nappies/diapers and adult incontinence garments. By the time the case came to trial, the patentee had made both unconditional and conditional applications to amend the claims of […]
READ MOREPosted: May 8th, 2017
The Court of Appeal recently handed down its decision in Synthon BV v Teva Pharmaceutical Industries Limited, upholding Birss J’s decision at first instance that Teva’s patent relating to glatiramer acetate (“GA”) (EP (UK) 2 361 924) was valid but that claim 20 and dependent claims were invalid for added matter. GA is a mixture […]
READ MOREPosted: March 27th, 2017
IPCom v HTC, UK Court of Appeal, 28 February 2017, neutral citation number [2017] EWCA Civ 90 The Court of Appeal has handed down the latest decision in the long running litigation between IPCom and HTC. IPCom had appealed the High Court’s decision that HTC’s smartphones did not infringe IPCom’s European Patent (UK) 1 841 […]
READ MOREPosted: January 6th, 2017
Novartis Ag v Focus Pharmaceuticals UK Ltd, UK, Court of Appeal, Lord Justice Kitchin, Lord Justice Floyd and Lord Justice Hamblen, 21 December 2016 This judgement was an appeal from a decision of Mr Justice Arnold who had previously found Novartis’ patent for transdermal patches containing rivastigmine used to prevent, treat or delay the progression […]
READ MOREPosted: December 21st, 2016
Merck Sharp and Dohme Limited v Shionogi & Co. Limited, High Court of England and Wales (Arnold J), 25 November 2015, Neutral Citation Number [2016] EWHC 2989 (Pat) The claimant, Merck, sought revocation of Shionogi’s EP(UK) 1 422 218. The defendant, Shionogi, counterclaimed for infringement by Merck’s integrase inhibitor raltegravir, marketed as Isentress. Shionogi made […]
READ MOREPosted: December 13th, 2016
Hewlett-Packard Development Company, L.P. (“HP”) v. Benson Image B.V., Top Printing B.V. and Agiostar B.V. (“Benson”), District Court of The Hague, the Netherlands, 30 November 2016, Case number 504637 / HA ZA 16-125 HP is the owner of European Patent EP 01 737 669 for a ‘fluid ejection device’, applied for on 6 April 2005 […]
READ MOREPosted: September 13th, 2016
Nicocigs Limited v. Fontem Holdings 1 BV, UK Patents Court, Mr John Baldwin QC, 2 September 2016, 2016 EWHC 2161 (Pat) In this action Nicocigs sought to revoke European Patent (UK) 2 022 349 and/or a declaration that its products did not infringe the patent. The patent concerned electronic cigarettes, a market that has expanded […]
READ MOREPosted: May 20th, 2016
GlaxoSmithKline UK Limited v Wyeth Holdings LLC, High Court of Justice of England & Wales (Patents Court), London, UK, Carr J, 12 May 2016, Neutral Citation Number: [2016] EWHC 1045 (CH) Carr J has upheld the validity of Wyeth’s patent EP(UK) 2,343,308 relating to a combination product comprising a 2086 protein and a PorA protein […]
READ MORE
EMAIL US
